Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,974 | 18,999 | 11,779 | 15,814 | 14,432 |
| Marketable Securities | 15,000 | 25,000 | 25,000 | 25,004 | 35,004 |
| Receivables | 10,698 | 9,332 | 8,216 | 6,307 | 8,726 |
| Inventories | 14,393 | 18,287 | 21,355 | 16,351 | 18,293 |
| Other current assets | 1,516 | 0 | 0 | 7,172 | 0 |
| TOTAL | $69,262 | $72,632 | $67,795 | $72,055 | $78,052 |
| Non-Current Assets | |||||
| PPE Net | 4,474 | 3,952 | 4,163 | 4,026 | 3,658 |
| Investments And Advances | 15,426 | 15,777 | 19,262 | 16,110 | 11,977 |
| Intangibles | 89,542 | 21,841 | 22,543 | 18,219 | 24,035 |
| Other Non-Current Assets | 2,191 | 150 | 150 | 5,321 | 150 |
| TOTAL | $111,633 | $41,719 | $46,118 | $43,676 | $39,820 |
| Total Assets | $180,895 | $114,352 | $113,912 | $115,732 | $117,872 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,195 | 2,285 | 2,548 | 3,284 | 4,531 |
| Accrued Expenses | 8,194 | 4,951 | 4,827 | 6,298 | 6,216 |
| Other current liabilities | 42,079 | N/A | N/A | N/A | N/A |
| TOTAL | $53,587 | $8,714 | $10,583 | $14,487 | $10,747 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 999 | N/A | 448 |
| Other Non-Current Liabilities | 12,871 | 685 | 0 | 1,898 | 0 |
| TOTAL | $14,895 | $3,504 | $3,642 | $2,819 | $2,606 |
| Total Liabilities | $68,482 | $12,218 | $14,225 | $17,306 | $13,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,269 | 28,306 | 25,887 | 25,885 | 25,807 |
| Common Shares | 283 | 260 | 259 | 259 | 258 |
| Retained earnings | -143,217 | -141,825 | -143,808 | -142,050 | -132,801 |
| Other shareholders' equity | 7,206 | 7,396 | 7,565 | 5,274 | 2,715 |
| TOTAL | $112,413 | $102,134 | $99,687 | $98,426 | $104,519 |
| Total Liabilities And Equity | $180,895 | $114,352 | $113,912 | $115,732 | $117,872 |